Advertisement

Leading Pharmaceutical Innovation

How to Win the Life Science Race

  • Oliver Gassmann
  • Alexander Schuhmacher
  • Max von Zedtwitz
  • Gerrit Reepmeyer

Table of contents

  1. Front Matter
    Pages i-xv
  2. Oliver Gassmann, Alexander Schuhmacher, Max von Zedtwitz, Gerrit Reepmeyer
    Pages 1-16
  3. Oliver Gassmann, Alexander Schuhmacher, Max von Zedtwitz, Gerrit Reepmeyer
    Pages 17-39
  4. Oliver Gassmann, Alexander Schuhmacher, Max von Zedtwitz, Gerrit Reepmeyer
    Pages 41-61
  5. Oliver Gassmann, Alexander Schuhmacher, Max von Zedtwitz, Gerrit Reepmeyer
    Pages 63-78
  6. Oliver Gassmann, Alexander Schuhmacher, Max von Zedtwitz, Gerrit Reepmeyer
    Pages 79-110
  7. Oliver Gassmann, Alexander Schuhmacher, Max von Zedtwitz, Gerrit Reepmeyer
    Pages 111-133
  8. Oliver Gassmann, Alexander Schuhmacher, Max von Zedtwitz, Gerrit Reepmeyer
    Pages 135-153
  9. Oliver Gassmann, Alexander Schuhmacher, Max von Zedtwitz, Gerrit Reepmeyer
    Pages 155-163
  10. Back Matter
    Pages 165-179

About this book

Introduction

This book investigates and highlights the most critical challenges the pharmaceutical industry faces in an increasingly competitive environment of inflationary R&D investments and tightening cost control pressures. The authors present three sources of pharmaceutical innovation: new management methods in the drug development pipeline; new technologies as enablers for cutting-edge R&D; and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. New models and methods are illustrated with cases from Europe, the US, and Asia. This third fully revised edition was expanded to reflect the latest updates in open and collaborative innovation, the greater strategic importance of venture capital and early-stage investments, and the new range of emerging technologies now being put to use in pharmaceutical innovation.

Health care innovation is possibly the greatest opportunity and challenge of our generation. This important book shows how pharmaceutical companies will continue to play an instrument role in making our lives better.

Stefan Thomke, William Barclay Harding Professor of Business Administration, Harvard Business School 

Very comprehensive review and analysis of current challenges for the biopharmaceutical industry. To stay competitive in this new technology driven environment, the industry started to develop new partnership models to close the innovation gap and provide patients with the relevant healthcare toolkits at the convergence of pharmaceuticals, diagnostics and IT technologies. Very exciting times ahead well depicted in this book!

Karima Boubekeur, VP Emerging Portfolio and Search & Evaluation, AstraZeneca

Great. The 3rd edition is not only an update. It’s an outstandingly featured summary on the challenges of pharma innovation.

Eckard von Keutz, SVP and Head of Early Development, Bayer Healthcare

Keywords

Pharmaceutical industry Pharmaceuticals Pharmacoeconomics Drug discovery Innovation R&D Innovation management R&D Management Science and technology Globalization

Authors and affiliations

  • Oliver Gassmann
    • 1
  • Alexander Schuhmacher
    • 2
  • Max von Zedtwitz
    • 3
  • Gerrit Reepmeyer
    • 4
  1. 1.Institute of Technology ManagementUniversity of St. GallenSt. GallenSwitzerland
  2. 2.Faculty of Applied ChemistryReutlingen UniversityReutlingenGermany
  3. 3.Department of Strategic ManagementKaunas University of TechnologyKaunasLithuania
  4. 4.NoviUSA

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-319-66833-8
  • Copyright Information Springer International Publishing AG, part of Springer Nature 2018
  • Publisher Name Springer, Cham
  • eBook Packages Business and Management
  • Print ISBN 978-3-319-66832-1
  • Online ISBN 978-3-319-66833-8
  • Buy this book on publisher's site
Industry Sectors
Pharma
Automotive
Chemical Manufacturing
Biotechnology
Finance, Business & Banking
Electronics
Consumer Packaged Goods
Energy, Utilities & Environment
Engineering